Wuhan YZY Biopharma Co., Ltd. Class H Financial Overview
Wuhan YZY Biopharma Co., Ltd. Class H's market cap is currently ―. The company's EPS TTM is HK$-0.326; its P/E ratio is ―; Wuhan YZY Biopharma Co., Ltd. Class H is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Currency in CNY
Wuhan YZY Biopharma Co., Ltd. Class H Earnings and Revenue History
